This inventor holds 8 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Ose Immunotherapeutics, National Institute of Health and Medical Research, The University of Nantes. Active years: 2022-2026.
Location History:
- Rezé, FR (2022)
- Reze, FR (2024)
Company Filing History:
8 out of 30 
3 out of 1,853 
3 out of 156 
Years Active: 2022-2026
Title: The Innovative Contributions of Vanessa Gauttier
Introduction
Vanessa Gauttier is a prominent inventor based in Rezé, France. She has made significant contributions to the field of immunotherapy, holding a total of seven patents. Her work focuses on developing innovative solutions for treating various medical conditions.
Latest Patents
Among her latest patents is the invention titled "Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof." This invention provides specific humanized anti-CLEC-1A antibodies that can bind to the CLEC-1A receptor, antagonizing its interaction with endogenous ligands. These compounds have the potential to treat deleterious conditions effectively. Another notable patent is related to the "Uses of anti-SIRPg antibodies," which outlines new applications for these antibodies in the treatment and prevention of autoimmune disorders or diseases.
Career Highlights
Throughout her career, Vanessa has worked with notable organizations such as Ose Immunotherapeutics and Université de Nantes. Her experience in these institutions has allowed her to advance her research and contribute to the development of groundbreaking therapies.
Collaborations
Vanessa has collaborated with esteemed colleagues, including Nicolas Poirier and Bernard Vanhove, to further her research and innovations in immunotherapy.
Conclusion
Vanessa Gauttier's work exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to advancing immunotherapy and improving patient outcomes.